Press Release

 

OPM publishes its 2025 half-yearly report
Financial
News
Press Release
Thu. 9 October 2025

OPM publishes its 2025 half-yearly report

Read more
OPM integrated the LRRK2 Investigative Therapeutics Exchange program from The Michael J. Fox Foundation
News
Press Release
Thu. 25 September 2025

OPM integrated the LRRK2 Investigative Therapeutics Exchange program from The Michael J. Fox Foundation

Read more
OPM announces its 2025 half-year financial results
Financial
News
Press Release
Thu. 31 July 2025

OPM announces its 2025 half-year financial results

Read more
5th Letter to Shareholders
Financial
News
Press Release
Thu. 17 July 2025

5th Letter to Shareholders

Read more
OPM announces equity financing of up to 5 million euros
Financial
News
Press Release
Thu. 17 April 2025

OPM announces equity financing of up to 5 million euros

Read more
OPM announces its 2024 annual results and clinical developments
Financial
News
Press Release
Thu. 3 April 2025

OPM announces its 2024 annual results and clinical developments

Read more
OPM announces Protocol Submission for its Phase 1b/2a Study
News
Press Release
Mon. 24 March 2025

OPM announces Protocol Submission for its Phase 1b/2a Study

Read more
Nomination of Christophe Thurieau as an independent member of OPM Board of Directors
News
Press Release
Tue. 4 March 2025

Nomination of Christophe Thurieau as an independent member of OPM Board of Directors

Read more
4th Letter to Shareholders
Financial
News
Press Release
Mon. 6 January 2025

4th Letter to Shareholders

Read more